Back to Search
Start Over
Biogen's Lecanemab launched in China to treat Alzheimer's Disease Use symbol Eisai
- Source :
- The Fly. June 27, 2024
- Publication Year :
- 2024
-
Abstract
- The company states: 'Eisai (ESAIY) and Biogen (BIIB) announced that the humanized anti-soluble aggregated amyloid-beta monoclonal antibody 'LEQEMBI' (generic name: lecanemab) has been launched in China. LEQEMBI received approval in [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.799224128